Document is current
Any future updates will be listed below
-
Authors
Rob, Daniel
Farkasovska, Klaudia
Kreckova, Marketa
Smid, Ondrej
Kavalkova, Petra
Macoun, Jaromir
Huptych, Michal
Havrankova, Petra
Gallo, Juraj
Pudil, Jan
Dusik, Milan
Havranek, Stepan
Linhart, Ales
Belohlavek, Jan http://orcid.org/0000-0001-9455-9224
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01511666 at ClinicalTrials.govDocuments that mention this clinical trial
Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation and immediate invasive assessment in refractory out-of-hospital cardiac arrest: a long-term follow-up of the Prague OHCA trial
https://doi.org/10.1186/s13054-024-04901-7
Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a secondary analysis of the Prague OHCA trial
https://doi.org/10.1186/s13054-022-04199-3
Extracorporeal cardiopulmonary resuscitation probably good, but adoption should not be too fast and furious!
https://doi.org/10.1136/emermed-2016-206442
Authors’ response: Extracorporeal cardiopulmonary resuscitation probably good, but adoption should not be too fast and furious!
https://doi.org/10.1136/emermed-2017-206801
-
Funding
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165, MH CZ – DRO - VFN00064165)
Univerzita Karlova v Praze (Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine, Cooperatio – Intensive Care Medicine)
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 3 April 2024
First Online: 16 April 2024
Declarations
:
: The study was approved by the Institutional Review Board of the General University Hospital and First Faculty of Medicine, Charles University, Prague. Each participant's legal representative was informed of the study enrollment and asked for written informed consent as soon as possible. All patients who regained normal neurological function were asked to provide written permission to use their data. Consent requirements were waived for patients who died at the scene and never reached the hospital and those without known legal representatives. The trial complied with the Declaration of Helsinki and is registered at ExternalRef removed (ClinicalTrials.gov Identifier: NCT01511666).
: The corresponding author (JB) has received lecture honoraria from the Abiomed, Getinge, Xenios, Resuscitec, Novartis, Astra-Zeneca, Boegringer-Ingelheim. DR has received lecture honoraria from the Abiomed and Resuscitec. The remaining authors report no conflict of interest.
